Over the past three years, additional insurance fraud cases have emerged involving AstraZeneca employees in various Chinese regions. The investigation focuses on potential breaches of data privacy ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

Nov 5 (Reuters) - AstraZeneca (AZN.L), opens new tab shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be ...

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.

The trial has shown that treatment can "achieve control of the disease but not a cure," Carel le Roux, MD, PhD, of University ...

AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday, falling 8.4 per cent, following a report ...

Pharma giant AstraZeneca was among London’s biggest losers ... including one count of stealing €500,000 from Bank of Ireland ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

Cellectis is confident about the continued progress of its ongoing clinical trials in hematological malignancies and is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...